Literature DB >> 18436324

Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite.

Mei Ling Ho1, Yin Chih Fu, Gwo Jaw Wang, Hui Ting Chen, Je Ken Chang, Tsung Hsien Tsai, Chih Kuang Wang.   

Abstract

This study relates to the Bovine Serum Albumin (BSA) protein-controlled release system with Poly(lactic-glycolic acid) (PLGA) biodegradable polymer. It also has special double emulsification carriers containing alkaline material of hydroxyapatite (HAp), which can carry the hydrophilic drug effectively and sustain a controlled substance release. The controlled release strategy is based on the HAp absorption ability, which will be trapped into the core of PLGA microsphere. Besides, the acidic degradation products of PLGA polymer and basic inorganic component of HAp can be used to control the dissolution of microsphere, then resulting in protein release. We have varied the HAp amount to observe its effect on microsphere characteristics such as the particle size, surface/internal morphology, BSA entrapment efficiency, microsphere degradation, BSA in vitro release behaviour, and cell toxicity etc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436324     DOI: 10.1016/j.jconrel.2008.02.012

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  18 in total

Review 1.  Organic-inorganic composites for bone drug delivery.

Authors:  Chidambaram Soundrapandian; Biswanath Sa; Someswar Datta
Journal:  AAPS PharmSciTech       Date:  2009-10-20       Impact factor: 3.246

2.  Hollow hydroxyapatite microspheres/chitosan composite as a sustained delivery vehicle for rhBMP-2 in the treatment of bone defects.

Authors:  Ai-Hua Yao; Xu-Dong Li; Long Xiong; Jian-Hua Zeng; Jun Xu; De-Ping Wang
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

3.  Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.

Authors:  Kaihui Nan; Feiyan Ma; Huiyuan Hou; William R Freeman; Michael J Sailor; Lingyun Cheng
Journal:  Acta Biomater       Date:  2014-05-02       Impact factor: 8.947

4.  Working together: interactions between vaccine antigens and adjuvants.

Authors:  Christopher B Fox; Ryan M Kramer; Lucien Barnes V; Quinton M Dowling; Thomas S Vedvick
Journal:  Ther Adv Vaccines       Date:  2013-05

5.  Reduction of inflammatory responses and enhancement of extracellular matrix formation by vanillin-incorporated poly(lactic-co-glycolic acid) scaffolds.

Authors:  Yujung Lee; Jeongil Kwon; Gilson Khang; Dongwon Lee
Journal:  Tissue Eng Part A       Date:  2012-06-12       Impact factor: 3.845

6.  Osteonecrosis of the femoral head: treatment with ancillary growth factors.

Authors:  Matthew T Houdek; Cody C Wyles; Rafael J Sierra
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

7.  Hydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: absorption and release kinetics in vitro.

Authors:  Guangping Xie; Jiao Sun; Gaoren Zhong; Changsheng Liu; Jie Wei
Journal:  J Mater Sci Mater Med       Date:  2010-03-19       Impact factor: 3.896

8.  The effect of temozolomide/poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite microspheres on glioma U87 cells behavior.

Authors:  Dongyong Zhang; Ang Tian; Xiangxin Xue; Mei Wang; Bo Qiu; Anhua Wu
Journal:  Int J Mol Sci       Date:  2012-01-19       Impact factor: 6.208

9.  Coaxial Electrospray of Curcumin-Loaded Microparticles for Sustained Drug Release.

Authors:  Shuai Yuan; Fan Lei; Zhongfa Liu; Qingping Tong; Ting Si; Ronald X Xu
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

10.  Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.

Authors:  Hua Wang; Jun Liu; Shan Tao; Guihong Chai; Jianwei Wang; Fu-Qiang Hu; Hong Yuan
Journal:  Int J Nanomedicine       Date:  2015-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.